Ian Scott joined the firm in 2012 as a member of the Intellectual Property Practice Group in the firm's New York office. Ian's practice is concentrated on patent litigation, with an emphasis in pharmaceutical patent litigation under the Hatch-Waxman Act. He has extensive experience in the preparation of legal opinions in connection with planning for litigation, including opinions regarding patentability, invalidity, freedom-to-operate and priority of invention of U.S. patents and publications.
Ian also provides counseling for clients in connection with the protection of their intellectual property rights and avoidance of third-party rights. He is experienced in all areas of the preparation, prosecution and exploitation of patent applications, including licensing of intellectual property rights and due diligence analyses. He counsels clients in a broad array of technical fields, including pharmaceuticals and pharmaceutical formulations, chemistry and chemical processes, industrial gases and related applications, medical devices, small molecules, polymers, polymer blends and dispersions, UV absorbers, cosmetics and golf equipment.
Prior to practicing law, Ian worked for more than nine years in the chemical industry, becoming a senior chemist at E.M. Industries, an affiliate of Merck KGaA, Darmstadt. He carried out and oversaw applied research and development in the areas of specialty pigments and sunscreen active materials, and the formulation of related personal care products. He also carried out research and development in the area of solution phase deposition processes. Ian also participated in the commercialization and marketing of specialty pigment, sunscreen active and chemical raw material products.
He earned his master's degree in chemistry from St. John's University and his bachelor's degree in chemistry, with honors, from University College Swansea, University of Wales. He graduated from Pace University School of Law in 1996.